- Home
- NRXP vs CURI Comparison
NRXP vs CURI Comparison
Compare NRXP & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | CURI |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 153.7M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NRXP | CURI |
|---|---|---|
| Price | $2.45 | $2.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $38.75 | $5.33 |
| AVG Volume (30 Days) | ★ 1.3M | 479.8K |
| Earning Date | 11-24-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 14.11% |
| EPS Growth | ★ 69.70 | 54.17 |
| EPS | N/A | ★ 0.12 |
| Revenue | $1,225,000.00 | ★ $78,043,000.00 |
| Revenue This Year | $357.94 | $10.59 |
| Revenue Next Year | $1,281.36 | $12.05 |
| P/E Ratio | ★ N/A | $19.92 |
| Revenue Growth | N/A | ★ 9.52 |
| 52 Week Low | $1.65 | $2.30 |
| 52 Week High | $5.06 | $5.10 |
Technical Indicators
Market Signals| Indicator | NRXP | CURI |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 33.27 |
| Support Level | $1.68 | $2.32 |
| Resistance Level | $2.49 | $2.96 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 50.00 | 4.35 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.